Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Depreciation and Depletion (2022 - 2023)

Historic Depreciation and Depletion for Phathom Pharmaceuticals (PHAT) over the last 2 years, with Q3 2023 value amounting to $100000.0.

  • Phathom Pharmaceuticals' Depreciation and Depletion fell 5000.0% to $100000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $400000.0, marking a year-over-year change of. This contributed to the annual value of $600000.0 for FY2022, which is 2000.0% up from last year.
  • As of Q3 2023, Phathom Pharmaceuticals' Depreciation and Depletion stood at $100000.0, which was down 5000.0% from $100000.0 recorded in Q2 2023.
  • Over the past 5 years, Phathom Pharmaceuticals' Depreciation and Depletion peaked at $200000.0 during Q3 2022, and registered a low of $100000.0 during Q1 2022.